Empiric use of cefepime in the treatment of lower respiratory tract infections in children

Pediatric Infectious Disease Journal

Volumn 20, Issue 3, 2001, Pages 343-349

  Bradley, John S ^a   Arrieta, Antonio ^b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Cefepime; Fourth generation cephalosporin; Lower respiratory tract infections; Pediatrics; Pneumonia

Indexed keywords

CEFEPIME; CEFTAZIDIME; CLINDAMYCIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERADICATION THERAPY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY DISTRESS;

ADOLESCENT; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; HUMANS; INFANT; RECURRENCE; RESPIRATORY TRACT INFECTIONS; SAFETY; TREATMENT OUTCOME;

EID: 0035078885     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200103000-00033     Document Type: Article

References (20)

1. Hospitalization for lower respiratory tract illness in infants: Variation in rates among counties in New York State and areas within Monroe County
2. Antibiotic therapy of childhood pneumonia
3. Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia
4. Childhood community-acquired pneumonia
5. Etiology and treatment of community-acquired pneumonia in ambulatory children
6. Predominant pathogens in hospital infections
7. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System
8. Nosocomial infections in pediatric intensive care units in the United States: National Nosocomial Infections Surveillance System
9. Cefepime: A fourth-generation parenteral cephalosporin
10. Cefepime
11. Cefepime: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
12. Cefepime: Microbiological profile and update
13. General guidelines for the evaluation of new anti-infective drugs for the treatment of respiratory tract infections
14. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species
15. Clinical outcomes of cefepime: Treatment of infections caused by ESBL- and AmpC-producing Enterobacteriaceae
16. Cefepime vs. ceftazidime treatment of pyelonephritis: A European, randomized, controlled study of 300 pediatric cases
17. Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children
18. Cefepime versus ceftazidime in the empiric treatment of febrile neutropenic children with malignancy
19. Cefepime versus ceftazidime in the treatment of lower respiratory tract infections
20. A comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infections